Jess S. Morgan & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.01M | Buy |
50,523
+477
| +1% | +$37.8K | 3.49% | 10 |
|
|
2022
Q2 | $3.72M | Buy |
50,046
+4,773
| +11% | +$354K | 3.85% | 9 |
|
|
2022
Q1 | $4.07M | Buy |
45,273
+6,582
| +17% | +$592K | 2.96% | 15 |
|
|
2021
Q4 | $4.33M | Buy |
38,691
+2,659
| +7% | +$298K | 2.66% | 21 |
|
|
2021
Q3 | $4.53M | Buy |
36,032
+3,680
| +11% | +$463K | 2.99% | 14 |
|
|
2021
Q2 | $4.38M | Buy |
32,352
+4,392
| +16% | +$595K | 2.88% | 14 |
|
|
2021
Q1 | $3.79M | Sell |
27,960
-471
| -2% | -$63.9K | 2.66% | 18 |
|
|
2020
Q4 | $4M | Buy |
28,431
+828
| +3% | +$117K | 3.19% | 8 |
|
|
2020
Q3 | $3.08M | Sell |
27,603
-1,113
| -4% | -$124K | 3.07% | 11 |
|
|
2020
Q2 | $3.22M | Sell |
28,716
-7,139
| -20% | -$799K | 3.49% | 6 |
|
|
2020
Q1 | $2.78M | Buy |
35,855
+3,926
| +12% | +$304K | 3.61% | 8 |
|
|
2019
Q4 | $3.04M | Buy |
+31,929
| New | +$3.04M | 2.98% | 11 |
|